Inside the womb, something remarkable is happening: the maternal immune system is quietly programming the infant's defenses in ways that could reduce the risk of developing type 1 diabetes by as much as half. Researchers at Umeå University have discovered that this protective effect occurs independent of genetics—a finding that rewrites what we thought we knew about how disease risk takes shape before birth.
The discovery matters because type 1 diabetes is one of the most common autoimmune disorders in children, yet its causes remain poorly understood. Scientists have long assumed that genes determine who will develop the disease and who won't. But Kristina Lejon, professor in the Department of Clinical Microbiology at Umeå University, and her team found that the prenatal environment exerts a profound influence that works alongside—and sometimes against—genetic predisposition.
To isolate the effect of the womb from genetics, the researchers conducted an elegant experiment. They transferred embryos from NOD mice, a strain that spontaneously develops type 1 diabetes, into pregnant females of a different strain, B6. This meant the developing mice had the genetic code for diabetes but were gestating in a different maternal environment. The results were striking: NOD mice carried by B6 females showed roughly a 50% lower incidence of type 1 diabetes compared to NOD mice carried by NOD females. Both groups developed comparable levels of inflammatory infiltration in the pancreas, suggesting the difference lay not in whether inflammation occurred, but in how well the immune system could regulate it.
When the team examined the immune systems of mice born to B6 mothers, they found long-lasting changes. The immune landscape appeared more balanced, with increased numbers of cells that suppress excessive immune responses and altered patterns of self-reactive antibodies—the hallmark signature of a more tolerant immune system. Emma Renman, research engineer in the same department, points to a compelling explanation: antibodies transferred through the placenta during pregnancy may prime the fetal immune system in ways that promote lasting self-tolerance.
The researchers carefully ruled out alternative explanations. They confirmed that genetic differences between the strains couldn't account for the effect, and that postnatal influences from the mother's gut microbiota—bacteria passed to offspring—were not responsible. This narrowed the mechanism to something happening during pregnancy itself, likely through maternal immune factors crossing the placental barrier.
"This shows that maternal factors can shape the offspring's immune system in a deeper way than previously understood," Lejon says. The implications extend far beyond mouse models. If similar mechanisms operate in humans, it suggests that conditions during pregnancy—maternal infections, nutrition, immune status—could influence a child's lifelong susceptibility to autoimmune disease. The findings open a new frontier in prevention, raising the possibility that interventions during pregnancy might one day reduce the incidence of type 1 diabetes and other autoimmune conditions.
The study, published in the journal Autoimmunity, marks a significant step toward understanding how early life shapes our immune destiny.